111 related articles for article (PubMed ID: 32718197)
1. Fucoidan Ameliorates Hepatocellular Carcinoma Induced in Rats: Effect on miR143 and Inflammation.
El-Far YM; Khodir AE; Emarah ZA; Ebrahim MA; Al-Gayyar MMH
Nutr Cancer; 2021; 73(8):1498-1510. PubMed ID: 32718197
[TBL] [Abstract][Full Text] [Related]
2. QNZ alleviated hepatocellular carcinoma by targeting inflammatory pathways in a rat model.
Al-Gayyar MMH; Alattar A; Alshaman R; Hamdan AM
Cytokine; 2021 Dec; 148():155710. PubMed ID: 34564023
[TBL] [Abstract][Full Text] [Related]
3. Fucoidan Elevates MicroRNA-29b to Regulate DNMT3B-MTSS1 Axis and Inhibit EMT in Human Hepatocellular Carcinoma Cells.
Yan MD; Yao CJ; Chow JM; Chang CL; Hwang PA; Chuang SE; Whang-Peng J; Lai GM
Mar Drugs; 2015 Sep; 13(10):6099-116. PubMed ID: 26404322
[TBL] [Abstract][Full Text] [Related]
4. Curative effects of fucoidan on acetic acid induced ulcerative colitis in rats via modulating aryl hydrocarbon receptor and phosphodiesterase-4.
Bagalagel A; Diri R; Noor A; Almasri D; Bakhsh HT; Kutbi HI; Al-Gayyar MMH
BMC Complement Med Ther; 2022 Jul; 22(1):196. PubMed ID: 35870906
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of blocking β-catenin against hepatocellular carcinoma-induced activation of inflammation, fibrosis and tumor invasion.
Hassan HM; El-Kannishy SMH; Alattar A; Alshaman R; Hamdan AM; Al-Gayyar MMH
Biomed Pharmacother; 2021 Mar; 135():111216. PubMed ID: 33433352
[TBL] [Abstract][Full Text] [Related]
6. Nimbolide inhibits tumor growth by restoring hepatic tight junction protein expression and reduced inflammation in an experimental hepatocarcinogenesis.
Ram AK; Vairappan B; Srinivas BH
World J Gastroenterol; 2020 Dec; 26(45):7131-7152. PubMed ID: 33362373
[TBL] [Abstract][Full Text] [Related]
7. Selenium nanoparticles and quercetin suppress thioacetamide-induced hepatocellular carcinoma in rats: Attenuation of inflammation involvement.
Mohamed AA; Zaghloul RA; Abdelghany AM; El Gayar AM
J Biochem Mol Toxicol; 2022 Apr; 36(4):e22989. PubMed ID: 35179263
[TBL] [Abstract][Full Text] [Related]
8. Triterpenoids principle of Wedelia calendulacea attenuated diethynitrosamine-induced hepatocellular carcinoma via down-regulating oxidative stress, inflammation and pathology via NF-kB pathway.
Verma A; Singh D; Anwar F; Bhatt PC; Al-Abbasi F; Kumar V
Inflammopharmacology; 2018 Feb; 26(1):133-146. PubMed ID: 28608141
[TBL] [Abstract][Full Text] [Related]
9. Fucoidan reduces inflammatory response in a rat model of hepatic ischemia-reperfusion injury.
Li XJ; Ye QF
Can J Physiol Pharmacol; 2015 Nov; 93(11):999-1005. PubMed ID: 26485583
[TBL] [Abstract][Full Text] [Related]
10. The Ameliorative Effects of Fucoidan in Thioacetaide-Induced Liver Injury in Mice.
Tsai MY; Yang WC; Lin CF; Wang CM; Liu HY; Lin CS; Lin JW; Lin WL; Lin TC; Fan PS; Hung KH; Lu YW; Chang GR
Molecules; 2021 Mar; 26(7):. PubMed ID: 33808318
[TBL] [Abstract][Full Text] [Related]
11. Selective cytotoxic activity and protective effects of sodium ascorbate against hepatocellular carcinoma through its effect on oxidative stress and apoptosis
El-Far YM; Khodir AE; Noor AO; Almasri DM; Bagalagel AA; Diri RM; Kutbi HI; Al-Gayyar MMH
Redox Rep; 2020 Dec; 25(1):17-25. PubMed ID: 32172678
[No Abstract] [Full Text] [Related]
12. Fucoidan ameliorates steatohepatitis and insulin resistance by suppressing oxidative stress and inflammatory cytokines in experimental non-alcoholic fatty liver disease.
Heeba GH; Morsy MA
Environ Toxicol Pharmacol; 2015 Nov; 40(3):907-14. PubMed ID: 26498267
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antiglypican-3 therapy as a promising target for amelioration of hepatic tissue damage in hepatocellular carcinoma.
Zaghloul RA; El-Shishtawy MM; El Galil KH; Ebrahim MA; Metwaly AA; Al-Gayyar MM
Eur J Pharmacol; 2015 Jan; 746():353-62. PubMed ID: 25449037
[TBL] [Abstract][Full Text] [Related]
14. Low-Molecular-Weight Fucoidan Inhibits the Viability and Invasiveness and Triggers Apoptosis in IL-1β-Treated Human Rheumatoid Arthritis Fibroblast Synoviocytes.
Shu Z; Shi X; Nie D; Guan B
Inflammation; 2015 Oct; 38(5):1777-86. PubMed ID: 25787883
[TBL] [Abstract][Full Text] [Related]
15. Chemopreventive and hepatoprotective effects of genistein via inhibition of oxidative stress and the versican/PDGF/PKC signaling pathway in experimentally induced hepatocellular carcinoma in rats by thioacetamide.
El-Far YM; Khodir AE; Emarah ZA; Ebrahim MA; Al-Gayyar MMH
Redox Rep; 2022 Dec; 27(1):9-20. PubMed ID: 35080474
[TBL] [Abstract][Full Text] [Related]
16. Umbelliferon-α-d-glucopyranosyl-(2
Kumar V; Bhatt PC; Rahman M; Al-Abbasi FA; Anwar F; Verma A
Biomed Pharmacother; 2017 Oct; 94():834-842. PubMed ID: 28802237
[TBL] [Abstract][Full Text] [Related]
17. Effect of fucoidan on the biotinidase kinetics in human hepatocellular carcinoma.
Hayakawa K; Nagamine T
Anticancer Res; 2009 Apr; 29(4):1211-7. PubMed ID: 19414366
[TBL] [Abstract][Full Text] [Related]
18. Pomegranate phytoconstituents blunt the inflammatory cascade in a chemically induced rodent model of hepatocellular carcinogenesis.
Bishayee A; Thoppil RJ; Darvesh AS; Ohanyan V; Meszaros JG; Bhatia D
J Nutr Biochem; 2013 Jan; 24(1):178-87. PubMed ID: 22841394
[TBL] [Abstract][Full Text] [Related]
19. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells.
Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
Biomed Pharmacother; 2016 Oct; 83():607-616. PubMed ID: 27459117
[TBL] [Abstract][Full Text] [Related]
20. Perturbation of MicroRNA-370/Lin-28 homolog A/nuclear factor kappa B regulatory circuit contributes to the development of hepatocellular carcinoma.
Xu WP; Yi M; Li QQ; Zhou WP; Cong WM; Yang Y; Ning BF; Yin C; Huang ZW; Wang J; Qian H; Jiang CF; Chen YX; Xia CY; Wang HY; Zhang X; Xie WF
Hepatology; 2013 Dec; 58(6):1977-91. PubMed ID: 23728999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
